EN
登录

医疗保健不需要更多的大科技;它需要专业技术

Healthcare Doesn’t Need More Big Tech; It Needs Specialized Tech

MedCity News 等信源发布 2023-11-13 22:24

可切换为仅中文


Just like clinicians who specialize in an area of medicine, healthcare’s tech problems need specialized solutions. That’s because the industry doesn’t have a single general issue to solve, healthcare has many discrete issues to address.

就像专注于医学领域的临床医生一样,医疗保健技术问题需要专门的解决方案。这是因为该行业没有一个需要解决的一般问题,医疗保健有许多不连续的问题需要解决。

To further complicate things, healthcare is not one industry but many industries under the same umbrella. Clinical care, devices, diagnostics, pharmaceuticals, hospitals, payers and more and each has its own unique challenges and opportunities that need to be addressed with unique solutions.

使事情进一步复杂化,医疗保健不是一个行业,而是许多行业在同一保护伞下。临床护理,设备,诊断,药品,医院,付款人等等,每个人都有自己独特的挑战和机遇,需要通过独特的解决方案加以解决。

It’s easy to oversimplify and say, “These big tech companies are now doing healthcare and they’re going to solve everything.” But the reality is that often, the solutions are not going to come from big tech.

过度简单化并说:“这些大技术公司现在正在做医疗保健,他们将解决一切问题。”但现实情况往往是,解决方案不会来自大技术。

Our healthcare system is built on a series of complex requirements and regulations that conventional technology solutions aren’t built for. Patient data privacy, regulatory compliance, interoperability, and the sensitivity of medical information call for a specialized set of solutions. A solution for a payment issue isn’t the same as a solution for patient records or network construction, telehealth, provider data, or a condition-specific issue..

我们的医疗保健系统建立在传统技术解决方案未建立的一系列复杂要求和法规之上。患者数据隐私,法规遵从性,互操作性和医疗信息的敏感性需要一套专门的解决方案。支付问题的解决方案与患者记录或网络构建,远程医疗,提供者数据或特定条件问题的解决方案不同。。

These individual problems are being addressed by legions of innovative people working in smaller, more focused organizations where they are experimenting, iterating, pivoting, and getting closer and closer to solutions to the issue they’re addressing. These teams are focusing on singular issues and solutions in a way that bigger, more general tech doesn’t..

这些个人问题正在由在更小,更集中的组织中工作的创新人员解决,他们正在试验,迭代,枢转,并且越来越接近他们正在解决的问题的解决方案。这些团队专注于单一问题和解决方案,而更大,更通用的技术则不然。。

To compound the issue, healthcare is an ever-changing industry and requires solution providers to be agile in order to keep up with emerging trends, new discoveries, new regulations, and shifts in patient and provider preferences. These smaller more specialized companies may not have the resources of large tech enterprises; however, they are inherently more adept at quickly iterating solutions, responding to changes, and adapting to evolving needs..

为了解决这个问题,医疗保健是一个不断变化的行业,要求解决方案提供商敏捷,以跟上新兴趋势,新发现,新法规以及患者和提供者偏好的变化。这些规模较小,专业化程度较高的公司可能没有大型科技企业的资源;然而,他们天生更擅长快速迭代解决方案,应对变化并适应不断变化的需求。。

This is why specialized solutions and specialized tech providers are ultimately going to be the problem solvers.

这就是为什么专业解决方案和专业技术提供商最终将成为问题解决者的原因。

Does this mean that big tech doesn’t have a place? Of course not. Big tech can do what big tech does best: identify, vet, and foster some of these solutions and ultimately scale the right ones.

这是否意味着大技术没有地位?当然不是。大技术可以做大技术最好的事情:确定,审查和培养其中一些解决方案,并最终扩展正确的解决方案。

But what about the funding? These entrepreneurial companies who are developing innovative tools are often start-ups and frequently raising capital at the same time they are building the solution.

但资金怎么样?这些正在开发创新工具的创业公司往往是初创企业,在构建解决方案的同时经常筹集资金。

A recent Pitchbook report covered by MedCity News included a mixed bag of news for these entrepreneurial companies in the medtech space. The report noted that venture capital funding to medtech appears to have bottomed out in the first quarter of this year and has been ticking slightly upward. That’s the good news.

MedCity News最近报道的一本投手手册报告包括medtech空间中这些创业公司的混合新闻。该报告指出,medtech的风险资本资金似乎在今年第一季度已经触底,并且一直略微上升。这是个好消息。

The troubling news is that this year’s medtech funding total may not reach the 2022 funding total of $13.5 billion and certainly won’t even approach the 2021 funding total of more than $19 billion..

令人不安的消息是,今年的medtech资金总额可能达不到2022年的135亿美元,而且肯定不会接近2021年的资金总额超过190亿美元。。

In healthcare the stakes are high, and any tech solution needs to operate as a “mission-critical” part of the equation. Think NASA or car safety where there are no margins for error or experimentation like there are if we were building a ridesharing or shopping app. We’re dealing with people’s health and lives on a daily basis.

在医疗保健领域,风险很高,任何技术解决方案都需要作为等式中“关键任务”的一部分。考虑一下NASA或汽车安全,如果我们正在构建搭便车或购物应用程序,那么没有错误或实验的余地。我们每天都在处理人们的健康和生活。

The stakes should be treated as life or death because they are. And the solutions we deploy need to be more than adequate. They need to be infallible..

风险应该被视为生死。我们部署的解决方案需要足够。他们需要绝对可靠。。

Photo: shylendrahoode, Getty Images

照片:Shylendrahode,Getty图片

Promoted

促进

Heard at HLTH: PurpleLab

在HLTH听到:PurpleLab

CEO Mark Brosso of PurpleLab talks about how the company specializes in gathering real world data and the steps taken to gather the correct data from disparate sources.

PurpleLab的首席执行官Mark Brosso谈到该公司如何专门收集现实世界的数据以及从不同来源收集正确数据所采取的步骤。

PurpleLab and MedCity News

PurpleLab和MedCity新闻

Promoted

促进

Heard at HLTH: Davita

在HLTH听到:达维塔

CEO of Davita Health, Javier Rodriquez talks about the importance value-based-care brings to its kidney patients He also discusses the company’s launch of the 2023 Davita Health Tour to help provide better health equity and community outreach.

Javier Rodriquez的Davita Health首席执行官谈到了基于价值的护理对肾病患者的重要性。他还讨论了该公司推出的2023年Davita健康之旅,以帮助提供更好的健康公平和社区外展。

Davita and MedCity News

Davita和MedCity新闻

Heard at HLTH: PurpleLab

在HLTH听到:PurpleLab

CEO Mark Brosso of PurpleLab talks about how the company specializes in gathering real world data and the steps taken to gather the correct data from disparate sources.

PurpleLab的首席执行官Mark Brosso谈到该公司如何专门收集现实世界的数据以及从不同来源收集正确数据所采取的步骤。

PurpleLab and MedCity News

PurpleLab和MedCity新闻

Heard at HLTH: Davita

在HLTH听到:达维塔

CEO of Davita Health, Javier Rodriquez talks about the importance value-based-care brings to its kidney patients He also discusses the company’s launch of the 2023 Davita Health Tour to help provide better health equity and community outreach.

Javier Rodriquez的Davita Health首席执行官谈到了基于价值的护理对肾病患者的重要性。他还讨论了该公司推出的2023年Davita健康之旅,以帮助提供更好的健康公平和社区外展。

Davita and MedCity News

Davita和MedCity新闻